- CBD LabChain is the all new blockchain data security platform crafted to provide CBD brands with a transparent, immutable certification of CBD lab test results
- No Borders Labs believes CBD LabChain offers a powerful tool to overcome common consumer concerns regarding trying or using hemp-derived CBD products
- No Borders continues its early filing tradition as a listed company on the OTC Market, reporting another record quarter of revenue growth
No Borders Inc. (OTC: NBDR), a multifaceted corporation specializing in the acquisition, creation and scaling of commercial and consumer products by utilizing cutting edge technologies to reduce costs while increasing revenues and shareholder value, has launched a revolutionary blockchain utilization platform specifically designed for the CBD industry. No Borders CEO and Chairman Joseph Snyder recently presented the company’s CBD LabChain platform to a wide audience of industry leaders and professionals attending Blockchain Expo 2019 in San Francisco (http://cnw.fm/Oc29w).
“I am very proud to share our product launch of CBD LabChain,” Snyder stated in the official launch video (http://cnw.fm/6H2pi). “Our product line, NoBordersNaturals.com, is in our humble opinion the finest line of CBD products on the market today. As of today, CBD LabChain is an immutable, secure, permanent record of all of the data, lab test results, THC amounts, CBD amounts, and other pertinent spectrum result that are in the product line that we sell to our consumers today.”
No Borders Naturals is currently the only company in the world to record 100% of its third-party lab tests on the www.CBDLabChain.com platform. However, CBD LabChain, built with a Platform-as-a-Service (PaaS) revenue model, is now available to existing market participants to record their lab test results for a per-test fee, Snyder said. Results of lab test results are easily accessible via QR Code linkage.
No Borders recently reported its family of companies achieved quarter-over-quarter revenue growth of 25.57%, increasing gross margins by 7.44% to 42.47% in Q3 2019, versus 35.03% in the previous quarter. No Borders also completed and submitted its quarterly filings early, which is now a company tradition and one that demonstrates to stakeholders an ironclad commitment to internal brand growth.
“Clearly, this filing shows that the Company is deploying capital to its brands and businesses at almost a 100% rate,” Cynthia Tanabe, COO of No Borders Inc., stated in a news release (http://cnw.fm/7myzL). “This is a strong indicator of how much faster and farther the NBDR brands can go with the addition of capital through the Company’s recent SEC filings.”
For more information, visit the company’s website at www.NBDR.co
NOTE TO INVESTORS: The latest news and updates relating to NBDR are available in the company’s newsroom at http://cnw.fm/NBDR
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.cbdwire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.cbdwire.com
303.498.7722 Office
Editor@CBDWire.com
CBDWire is part of the InvestorBrandNetwork.
